SVF Investments (UK) Ltd's Net Worth
$10.5 Billion
Who is SVF Investments (UK) Ltd?
SVF Investments (UK) Ltd has an estimated net worth of $10.5 Billion. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., and Coupang, Inc..
SEC CIK
SVF Investments (UK) Ltd's CIK is 0001716729
Past Insider Trading and Trends
2019 was SVF Investments (UK) Ltd's most active year for acquiring shares with 28 total transactions. SVF Investments (UK) Ltd's most active month to acquire stocks was the month of May. 2022 was SVF Investments (UK) Ltd's most active year for disposing of shares, totalling 3 transactions. SVF Investments (UK) Ltd's most active month to dispose stocks was the month of February. 2018 saw SVF Investments (UK) Ltd paying a total of $161,399,997.55 for 28,738,300 shares, this is the most they've acquired in one year. In 2021 SVF Investments (UK) Ltd cashed out on 57,000,000 shares for a total of $1,692,045,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Coupang, Inc. (CPNG) Snapshot price: $14.355
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.77% | -46.61M |
$19.20 | -$894,927,187.28 | 349.54M |
Mar 12 - Mar 13
| |||
Form 4
| -7.04% | -30.00M |
$15.39 | -$461,700,000.00 | 396.16M |
Nov 29
| |||
Form 4
| -7.59% | -35.00M |
$18.50 | -$647,500,000.00 | 426.16M |
Dec 5
| |||
Form 4
| -9.78% | -50.00M |
$20.87 | -$1,043,500,000.00 | 461.16M |
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -9.12% | -57.00M |
$29.69 | -$1,692,045,000.00 | 568.16M |
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.4912
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.04% | -10.00M |
$12.60 | -$126,000,000.00 | 73.03M |
Sep 28
| |||
Form 4
| -12.63% | -12.00M |
$8.00 | -$96,000,000.00 | 83.03M |
Mar 20
| |||
Form 4
| -4.37% | -4.34M |
$4.75 | -$20,633,615.25 | 95.03M |
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.02% | 14.48K |
$7.64 | $110,461.18 | 68.24M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.10% | 21.61K |
$7.54 | $162,875.90 | 22.73M |
May 16 - May 20
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||